PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Recruiting now

Conditions studied: Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Non-resectable, Chemotherapy Effect

In brief

A prospective, nationwide, implementation program of the international standard of excellence for locally advanced pancreatic cancer (LAPC) care in the Netherlands (2021\[7\]-2030\[6\]), including a multidisciplinary training program by the four leading international expert centers. The PREOPANC-4 project aims a safe and patient-centered implementation of the international standards of excellence for LAPC (surgery) in the Netherlands.

Key facts

Study ID

NCT05524090

Run by

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

People needed

223

Starts

2021-07-01

Expected to finish

2030-12-31

Last updated by the study team

2022-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Pathology-confirmed (LAPC)*
• CT-based non-progressive disease (RECIST criteria) after at least 4 months of systemic chemotherapy ([m]FOLFIRINOX / gemcitabine-nab-paclitaxel).

You may not qualify if…

• Metastatic pancreatic cancer prior to induction chemotherapy.
• According to the Dutch Pancreatic Cancer Group (DPCG) definition: >90 degrees arterial tumor involvement (i.e. superior mesenteric artery, celiac axis, and/or hepatic artery) and/or portovenous involvement of either >270 degrees or occlusion.

Where it is running

• Amsterdam UMC, locatie AMC — Amsterdam, North Holland, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.